全文获取类型
收费全文 | 874篇 |
免费 | 37篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 53篇 |
妇产科学 | 12篇 |
基础医学 | 77篇 |
口腔科学 | 11篇 |
临床医学 | 85篇 |
内科学 | 106篇 |
皮肤病学 | 9篇 |
神经病学 | 81篇 |
特种医学 | 165篇 |
外科学 | 88篇 |
综合类 | 79篇 |
预防医学 | 40篇 |
眼科学 | 31篇 |
药学 | 58篇 |
中国医学 | 1篇 |
肿瘤学 | 35篇 |
出版年
2021年 | 7篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 10篇 |
2017年 | 12篇 |
2016年 | 11篇 |
2015年 | 23篇 |
2014年 | 23篇 |
2013年 | 30篇 |
2012年 | 33篇 |
2011年 | 24篇 |
2010年 | 20篇 |
2009年 | 19篇 |
2008年 | 27篇 |
2007年 | 33篇 |
2006年 | 50篇 |
2005年 | 22篇 |
2004年 | 27篇 |
2003年 | 17篇 |
2002年 | 17篇 |
2001年 | 29篇 |
2000年 | 20篇 |
1999年 | 18篇 |
1998年 | 36篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 26篇 |
1994年 | 26篇 |
1993年 | 33篇 |
1992年 | 18篇 |
1991年 | 12篇 |
1990年 | 21篇 |
1989年 | 19篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 28篇 |
1985年 | 13篇 |
1984年 | 17篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1974年 | 3篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1966年 | 5篇 |
排序方式: 共有933条查询结果,搜索用时 15 毫秒
131.
Although the majority of impalpable undescended testes lie in an intracanalicular location, a significant number are also found to be intraabdominal. The expected location of intraabdominal testes is a line joining the renal hilum and the internal inguinal ring. We describe a case of an adult patient in whom impalpable undescended testes were located in a retrovesical location. This case highlights the importance of performing a thorough inspection of the entire abdomen and pelvis if the impalpable testis is not found in an expected location. 相似文献
132.
133.
Airways and lung: correlation of CT with fiberoptic bronchoscopy 总被引:7,自引:0,他引:7
134.
P. J. Conlon J. J. Walshe R. O’Donnell A. O’Donohoe R. Spencer J. Donohoe M. Carmody 《Irish journal of medical science》1993,162(1):17-19
We treated 57 patients who suffered from end stage renal disease (ESRD) with recombinant human erythropoietin (EPO) for a mean period of 56 weeks. Patients were aged between 18 and 81 years. Forty three patients were on haemodialysis and 14 on continuous ambulatory peritoneal dialysis (CAPD). Despite regular transfusions, the mean haemoglobin prior to EPO therapy was 7.4 g/dl ± 1.7. The target haemoglobin of 10 g/dl was reached at a mean of 12 weeks for the CAPD patients and at 14 weeks for the haemodialysis population. Patients were noted during the study to have a progressive rise in mean red cell volume, and this appeared to be related to their level of iron stores. The mean dose of EPO used to reach the target haemglobin was 8,700 u/week (125 u/kg/week) for the haemodialysis patients and 7,200 u/week (102 u/kg/week) for the CAPD patients. Three patients (7%) developed thrombosis of their A/V fistula. Hypertension was exacerbated in 28% of the patients. We conclude that EPO is a very effective but not inexpensive therapy for the anaemia of ESRD. 相似文献
135.
136.
Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. 总被引:7,自引:4,他引:3
Steven D Weisbord Sharon S Carmody Frank J Bruns Armando J Rotondi Lewis M Cohen Mark L Zeidel Robert M Arnold 《Nephrology, dialysis, transplantation》2003,18(7):1345-1352
BACKGROUND: There has been little research on the potential value of palliative care for dialysis patients. In this pilot study, we sought (i) to identify symptom burden, health-related quality of life (HRQoL) and advance directives in extremely ill haemodialysis patients to determine their suitability for palliative care and (ii) to determine the acceptability of palliative care to patients and nephrologists. METHODS: Nineteen haemodialysis patients with modified Charlson co-morbidity scores of > or =8 were recruited. Each completed surveys to assess symptom burden, HRQoL and prior advance care planning. Palliative care specialists then visited patients twice and generated recommendations. Patients again completed the surveys, and dialysis charts were reviewed to assess nephrologists' (i) compliance with recommendations and (ii) documentation of symptoms reported by patients on the symptom assessment survey. Patients and nephrologists then completed surveys assessing their satisfaction with palliative care. RESULTS: Patients reported 10.5 symptoms, 40% of which were noted by nephrologists in patients' charts. HRQoL was significantly impaired. Thirty-two percent of patients had living wills. No differences were observed in symptoms, HRQoL or number of patients establishing advance directives as a result of the intervention. Sixty-eight percent of patients and 76% of nephrologists rated the intervention worthwhile. CONCLUSIONS: Extremely ill dialysis patients have marked symptom burden, considerably impaired HRQoL and frequently lack advance directives, making them appropriate candidates for palliative care. Patients and nephrologists perceive palliative care favourably despite its lack of effect in this study. A more sustained palliative care intervention with a larger sample size should be attempted to determine its effect on the care of this population. 相似文献
137.
138.
139.
140.